North America Blood Collection Devices Market Outlook (2025-2035)
The North America Blood Collection Devices market encompasses a diverse range of products utilized in clinical diagnostics, transfusion, research, and therapeutic applications. With rapid advancement in medical technologies and ongoing demand from healthcare institutions, this market is poised for significant growth. The market is influenced by increases in chronic disease prevalence, growing elderly population, improved healthcare infrastructure, and continuous product innovations from key industry players. The adoption of advanced automation and minimally invasive blood collection techniques further drives the sector. Major device types include needles, syringes, blood collection tubes, vacuum systems, and blood bags, with distribution spanning hospitals, diagnostic centers, blood banks, and more. The market is competitive, with dominance by several multinational companies and continuous new entrants bringing innovation.
Latest Market Dynamics
Key Drivers
- Rise in Chronic and Infectious Diseases: The increasing incidence of chronic conditions such as diabetes and cardiovascular ailments as well as infections necessitates frequent blood testing. Companies like Becton, Dickinson and Company are focusing on launching new devices tailored for ease and safety in blood collection, thereby capturing larger market shares.
- Technological Advancements and Automation: Technological improvements such as vacuum-assisted and automated blood collection devices enhance sample integrity and minimize human error. Terumo Corporation, for example, has recently expanded its offerings in fully automated blood collection solutions, streamlining workflow for clinical laboratories.
Key Trends
- Expansion in Point-of-Care Testing: The surge in decentralized healthcare has elevated demand for capillary blood collection devices and rapid diagnostics kits. Greiner Bio-One International GmbH is actively innovating in this segment to provide compact, user-friendly collection systems for point-of-care settings.
- Sustainability Initiatives and Single-Use Devices: Increasing regulatory scrutiny and eco-consciousness push market leaders like Fresenius Kabi AG to produce recyclable or biodegradable blood collection products, aligning with healthcare provider preferences for sustainable operations.
Key Opportunities
- Growth of Home Healthcare and Remote Diagnostics: The rise in telemedicine and home healthcare creates demand for user-friendly, safe, and minimally invasive blood collection kits. Haemonetics Corporation has invested in developing devices compatible with at-home use, improving access for patients with mobility challenges.
- Expansion into Emerging Markets within North America: Growing healthcare infrastructure and government investment in Mexico and underserved US regions present expansion opportunities for suppliers such as Cardinal Health, Inc., aiming to broaden product distribution networks and healthcare partnerships.
Key Challenges
- Stringent Regulatory Approval Processes: Regulatory hurdles can delay time-to-market for novel blood collection devices. Medtronic plc faces continued pressure to meet evolving FDA standards, impacting speed of innovation and adoption.
- Product Recalls and Compliance Issues: Quality concerns and device recalls can tarnish reputations and cause financial setbacks. In 2024, Nipro Medical Corporation had to manage a recall incident due to safety non-compliance, which affected stakeholder confidence and sales.
Key Restraints
- High Cost of Advanced Blood Collection Technologies: The introduction of fully automated and next-generation blood collection systems comes with substantial costs, making affordability a concern for small to mid-size healthcare settings. ICU Medical, Inc. faces challenges in pricing strategies to drive broader adoption.
- Limited Awareness and Training for New Devices: Many clinical staff remain unaware or untrained with respect to using newer blood collection systems, impacting market penetration. Smiths Medical is addressing this restraint by providing targeted training and support programs.
Market Share by Type (2025)
In 2025, blood collection tubes dominate the North America market, closely followed by needles and syringes. Blood bags, vacuum blood collection systems, lancets, and others collectively account for a smaller market share. This distribution reflects the essential use of blood collection tubes in diagnostics and research, aligning with increasing routine blood testing and integrated healthcare solutions. Manufacturers focusing on convenience, safety, and contamination prevention continue to invest in tube-based innovations, ensuring reliability for end-users. With regulatory focus on sample quality, tubes remain integral to clinical workflows. Other device types, though vital, cater to more specialized or less frequent collection needs.
Market Share by Application (2025)
Diagnostic applications hold the largest share in the market by application segment for 2025, followed by blood transfusion and therapeutics. Research, population health monitoring, and other sub-segments account for smaller portions. The dominance of diagnostics is attributed to increased prevalence of chronic and infectious diseases, routine health monitoring, and corporate wellness screening. Blood transfusion maintains a significant share due to high demand in hospitals and trauma centers. Therapeutics is steadily rising owing to advances in blood-borne therapies and precision medicine.
Market Revenue (USD Million, 2020-2035)
From 2020 to 2035, the North America Blood Collection Devices market is projected to experience substantial growth. The market revenue is expected to soar from 3,580 Million in 2021 to 6,730 Million in 2035, reflecting increased demand for blood collection devices driven by advancements in technology, expansion of healthcare infrastructure, and higher blood testing frequency. The upward trend highlights the role of innovation and improved healthcare access, with key companies investing in automation and user-friendly products to drive adoption across diverse settings.
Year-on-Year Growth Rate (%) (2020-2035)
The North America Blood Collection Devices Market shows a consistent year-on-year (YOY) growth rate from 2020 to 2035, with minor fluctuations in line with macroeconomic conditions and supply chain improvements. The YOY trend stretches from 6.2% in 2021 peaking at 9.5% in the post-pandemic boom, and stabilizing to around 7.6% by 2035, fueled by continuous innovations and healthcare system expansions.
Regional Market Share (2025)
The United States remains the largest market for blood collection devices in North America, accounting for 69% of the total market share in 2025, followed by Canada with an 18% share and Mexico at 13%. This regional distribution reflects the US's dominance in healthcare infrastructure and R&D activities, while Canada and Mexico are steadily increasing their market presence through improved healthcare funding and expanding hospital networks.
Top Players Market Share (2025)
Among the key market participants, Becton, Dickinson and Company leads with a 22% share, followed by Terumo Corporation and Greiner Bio-One International GmbH at 15% and 12% respectively. The rest of the market is shared among Fresenius Kabi AG, Haemonetics Corporation, Cardinal Health, and other players. This competitive landscape is characterized by frequent product launches, partnerships, and R&D investments aimed at gaining higher market shares.
Market Buyers Share (2025)
Hospitals continue to represent the largest buyer group for blood collection devices in North America (38%), succeeded by diagnostic centers (26%) and blood banks (19%). Ambulatory surgical centers, research & academic institutes, and others collectively form a smaller portion of the market. The buyer landscape is increasingly diversified with the expansion of outpatient care and home healthcare services.
Study Coverage
| Metrics | Details |
|---|
| Years | 2020-2035 |
| Base Year | 2025 |
| Market Size | 4120 |
| Regions | United States, Canada, Mexico |
| Segments | Needles and Syringes, Blood Collection Tubes, Lancets, Blood Bags, Vacuum Blood Collection Systems, Others; Diagnostics, Therapeutics, Blood Transfusion, Research, Others, Population Health Monitoring; Manual Blood Collection, Automated Blood Collection, Capillary Blood Collection, Plasma Separation Technologies, Serological Testing Technologies, Others; Hospitals, Diagnostic Centers, Blood Banks, Ambulatory Surgical Centers, Research & Academic Institutes, Others; Small, Medium, Large |
| Players | Becton, Dickinson and Company, Terumo Corporation, Greiner Bio-One International GmbH, Fresenius Kabi AG, Haemonetics Corporation, Cardinal Health, Inc., Sarstedt AG & Co. KG, Medtronic plc, Nipro Medical Corporation, Smiths Medical, FL Medical S.R.L., Retractable Technologies, Inc., AdvaCare Pharma, Kawasumi Laboratories, Inc., ICU Medical, Inc. |
Key Recent Developments
- June 2024: Becton, Dickinson and Company launched the BD UltraSafe™ Plus Blood Collection Set featuring enhanced user safety and sample integrity.
- July 2024: Terumo Corporation expanded its VACUETTE® Premium line with an innovative closed-system device for high-throughput laboratories.
- August 2024: Cardinal Health announced an exclusive partnership with a leading diagnostic network to supply next-gen automated blood collection tubes.
- September 2024: Greiner Bio-One received FDA clearance for its eco-friendly, recyclable blood collection tube series in North America.
- October 2024: Haemonetics Corporation introduced a new at-home blood collection kit, supporting the shift towards remote diagnostics and telemedicine.
